Total Payments
$2,513
2022 Payments
$28.14
Companies
30
Transactions
174
Medicare Patients
1,206
Medicare Billing
$95,480
Payment Breakdown by Category
Food & Beverage$2,439 (97.1%)
Education$73.20 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,439 | 169 | 97.1% |
| Education | $73.20 | 5 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $444.81 | 35 | $0 (2020) |
| GlaxoSmithKline, LLC. | $199.61 | 13 | $0 (2020) |
| Novo Nordisk Inc | $197.48 | 14 | $0 (2020) |
| Amarin Pharma Inc. | $192.57 | 20 | $0 (2019) |
| PFIZER INC. | $166.73 | 13 | $0 (2020) |
| Shire North American Group Inc | $154.67 | 8 | $0 (2018) |
| Astellas Pharma US Inc | $121.18 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $116.24 | 8 | $0 (2019) |
| ABBVIE INC. | $115.76 | 7 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $100.77 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $28.14 | 2 | ABBVIE INC. ($28.14) |
| 2020 | $145.86 | 10 | PFIZER INC. ($25.60) |
| 2019 | $821.84 | 62 | AstraZeneca Pharmaceuticals LP ($122.48) |
| 2018 | $772.15 | 52 | AstraZeneca Pharmaceuticals LP ($168.18) |
| 2017 | $744.65 | 48 | AstraZeneca Pharmaceuticals LP ($140.28) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Central Nervous System | ||||||
| 02/25/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/04/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Diabetes | ||||||
| 01/23/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology | ||||||
| 01/15/2020 | Bausch Health US, LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROLOGY | ||||||
| 01/15/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: VACCINES | ||||||
| 01/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/12/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/31/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 10/31/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/03/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Obesity | ||||||
| 09/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 09/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 20 | 20 | $5,600 | $869.70 |
| 2021 | 11 | 540 | 714 | $124,771 | $53,590 |
| 2020 | 11 | 646 | 742 | $104,582 | $41,020 |
Total Patients
1,206
Total Services
1,476
Medicare Billing
$95,480
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 20 | $5,600 | $869.70 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 298 | $75,140 | $28,121 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 91 | 91 | $21,294 | $12,567 | 59.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 19 | 19 | $6,783 | $3,389 | 50.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 45 | 45 | $4,230 | $2,920 | 69.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 13 | 13 | $4,955 | $2,288 | 46.2% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 29 | 29 | $3,074 | $1,238 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 18 | $3,150 | $1,219 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 47 | 47 | $1,880 | $854.52 | 45.5% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 11 | 11 | $1,166 | $469.59 | 40.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 96 | 129 | $2,245 | $384.98 | 17.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 14 | $854.00 | $140.58 | 16.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 204 | $46,920 | $14,260 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 87 | 87 | $20,358 | $10,774 | 52.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 81 | 82 | $7,708 | $4,915 | 63.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 80 | $12,400 | $3,953 | 31.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 21 | 21 | $7,497 | $3,796 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 89 | 90 | $3,600 | $1,598 | 44.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 14 | $1,330 | $443.14 | 33.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,045 | $392.32 | 37.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 95 | 116 | $1,740 | $343.38 | 19.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 24 | 24 | $1,464 | $312.98 | 21.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $520.00 | $232.30 | 44.7% |
About Dr. Gilbert Kasirsky, D.O
Dr. Gilbert Kasirsky, D.O is a Family Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609826429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Kasirsky, D.O has received a total of $2,513 in payments from pharmaceutical and medical device companies, with $28.14 received in 2022. These payments were reported across 174 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,439).
As a Medicare-enrolled provider, Kasirsky has provided services to 1,206 Medicare beneficiaries, totaling 1,476 services with total Medicare billing of $95,480. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Feasterville Trevose, PA
- Active Since 05/11/2006
- Last Updated 06/03/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609826429
Products in Payments
- FARXIGA (Drug) $390.75
- Vascepa (Drug) $192.57
- XIFAXAN (Drug) $136.39
- Livalo (Drug) $100.77
- CHANTIX (Drug) $96.98
- VYVANSE (Drug) $78.36
- MYDAYIS (Drug) $76.31
- Saxenda (Drug) $74.33
- JANUVIA (Drug) $73.74
- Androgel (Drug) $70.03
- Myrbetriq (Drug) $65.40
- ANORO (Drug) $57.78
- MYRBETRIQ (Drug) $55.78
- Trintellix (Drug) $49.50
- VRAYLAR (Drug) $49.17
- Ozempic (Drug) $46.84
- TRELEGY ELLIPTA (Drug) $46.05
- Adzenys XR-ODT (Drug) $44.14
- SYMBICORT (Drug) $40.42
- Repatha (Biological) $38.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Feasterville Trevose
John Mcdonald, D.o, D.O
Family Medicine — Payments: $9,701
Family Medicine $9,701
Dr. Si Lam, Do, DO
Family Medicine — Payments: $4,395
Family Medicine $4,395
Alberto Larrieu, Md, MD
Family Medicine — Payments: $3,114
Family Medicine $3,114
Sean Duffy, Do, DO
Family Medicine — Payments: $2,905
Family Medicine $2,905
Meredith Ray, Md, MD
Family Medicine — Payments: $1,540
Family Medicine $1,540
Douglas Kimmel, D.o, D.O
Family Medicine — Payments: $1,058
Family Medicine $1,058